Kaiser Health News

Fish Oil, Vitamin D Don't Prevent Cancer, Serious Heart Troubles

A clinical trial involving nearly 26,000 people showed these widely taken supplements don't affect rates of cancer diagnosis or serious heart issues but do appear to stem heart attacks and cancer deaths.

A widely anticipated study has concluded that neither vitamin D nor fish oil supplements prevent cancer or serious heart-related problems in healthy older people, according to research presented Saturday at the American Heart Association Scientific Sessions.

House Dems In New Seats Of Power Will Steer Health Policy, Attack Drug Prices

But Republicans’ tightened grip on the Senate means those hoping for another round of dramatic, progressive reforms may be disappointed.

For the first time since passing the Affordable Care Act, Democrats will soon control the House of Representatives and its powerful health committees. But Republicans’ tightened grip on the Senate means those hoping for another round of dramatic, progressive reforms may be disappointed.

Quick: What’s The Difference Between Medicare-For-All and Single-Payer?

Terms like single payer, public option and universal health care are bandied about, but few know exactly what they mean.

Across the country, catchphrases such as “Medicare-for-all,” “single-payer,” “public option” and “universal health care” are sweeping state and federal political races as Democrats tap into voter anger about GOP efforts to kill the Affordable Care Act and erode protections for people with preexis

Heart Drug Spotlights Troubling Trends In Drug Marketing

A company is marketing a drug intended as a preventive for people at risk for heart disease with stunning statistics but has not yet released details of its study.

At the end of September, Amarin Corp. teased some early findings for Vascepa, its preventive medicine for people at risk of heart disease. The claim was astounding: a 25 percent relative risk reduction for deaths related to heart attacks, strokes and other conditions.

With One Hand, Administration Boosts ACA Marketplaces, Weakens Them With Another

Guidance issued Monday could make it easier for states to get around some of the law's requirements while a rule proposed 12 hours later could bolster the exchanges.

In the span of less than 12 hours last week, the Trump administration took two seemingly contradictory actions that could have profound effects on the insurance marketplaces set up by the Affordable Care Act.

Medicare For All? CMS Chief Warns Program Has Enough Problems Already

Seema Verma, administrator for the Centers for Medicare & Medicaid, told insurance executives: “We face tremendous barriers to supporting and bringing innovation to Medicare."

The Trump administration’s top Medicare official has slammed the federal health program as riddled with problems that hinder care to beneficiaries, increase costs for taxpayers and escalate fraud and abuse.

Pages

Subscribe to Kaiser Health News